HCW Biologics Inc.
HCWB
$1.18
-$0.27-18.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 73.08% | 136.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 73.08% | 136.36% | |||
| Cost of Revenue | 72.80% | 140.38% | |||
| Gross Profit | 74.19% | 138.46% | |||
| SG&A Expenses | 90.85% | -15.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 50.82% | -4.69% | |||
| Operating Income | -50.72% | 4.97% | |||
| Income Before Tax | 115.79% | -136.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 115.79% | -136.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 115.79% | -136.26% | |||
| EBIT | -50.72% | 4.97% | |||
| EBITDA | -54.09% | 1.70% | |||
| EPS Basic | 49.17% | 70.31% | |||
| Normalized Basic EPS | 2.43% | 23.13% | |||
| EPS Diluted | 49.17% | 70.31% | |||
| Normalized Diluted EPS | 2.43% | 23.13% | |||
| Average Basic Shares Outstanding | 49.73% | 26.96% | |||
| Average Diluted Shares Outstanding | 49.73% | 26.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||